Overview
Announcements

Ordinary Adjustment | Solactive Global Genomics Immunology and Medical Revolution Index | Effective Date 5th June 2025

Solactive Global Genomics Immunology and Medical Revolution Index:

In the ordinary adjustment, the following composition will be implemented effective open 5th June 2025:

10X GENOMICS INC
ABBVIE INC
AGILENT TECHNOLOGIES INC
AMGEN INC
ASTRAZENECA PLC
AXSOME THERAPEUTICS INC
BEAM THERAPEUTICS INC
BIO-TECHNE CORP
BIOGEN INC
BIONTECH SE
BRIDGEBIO PHARMA INC
BRISTOL-MYERS SQUIBB CO
CRISPR THERAPEUTICS AG
ELI LILLY & CO
EXACT SCIENCES CORP
EXELIXIS INC
GENEDX HOLDINGS CORP
GENMAB A/S
GENSCRIPT BIOTECH CORP
GILEAD SCIENCES INC
GUARDANT HEALTH INC
ILLUMINA INC
INTELLIA THERAPEUTICS INC
IOVANCE BIOTHERAPEUTICS INC
JOHNSON & JOHNSON
LEGEND BIOTECH CORP
LONZA GROUP AG
MERCK & CO. INC.
MODERNA INC
NATERA INC
NOVARTIS AG
NOVO NORDISK A/S
PFIZER INC
PTC THERAPEUTICS INC
QIAGEN NV
RECURSION PHARMACEUTICALS INC
REGENERON PHARMACEUTICALS
REVVITY INC
SAMSUNG BIOLOGICS CO LTD
SANOFI SA
SAREPTA THERAPEUTICS INC
SCHOLAR ROCK HOLDING CORP
SUMMIT THERAPEUTICS PLC
TEVA PHARMACEUTICAL IND LTD
THERMO FISHER SCIENTIFIC INC
TWIST BIOSCIENCE CORP
ULTRAGENYX PHARMACEUTICAL INC
VERACYTE INC
VERTEX PHARMACEUTICALS INC
VIKING THERAPEUTICS INC